Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses

KC Chang, WW Yew, Y Zhang - Antimicrobial agents and …, 2011 - Am Soc Microbiol
Standard culture-based testing of the susceptibility of Mycobacterium tuberculosis to
pyrazinamide is difficult to perform. This systematic review with meta-analyses evaluated the …

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control

A Matteelli, GB Migliori, D Cirillo, R Centis… - Expert review of anti …, 2007 - Taylor & Francis
The emergence of multidrug-resistant (MDR)-TB and, more recently, of extensively drug-
resistant (XDR)-TB is a real threat to achieve TB control and elimination. Over 400,000 new …

Pyrazinamide and derivatives block ethylene biosynthesis by inhibiting ACC oxidase

X Sun, Y Li, W He, C Ji, P Xia, Y Wang, S Du… - Nature …, 2017 - nature.com
Ethylene is an important phytohormone that promotes the ripening of fruits and senescence
of flowers thereby reducing their shelf lives. Specific ethylene biosynthesis inhibitors would …

[HTML][HTML] PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection

G Costabile, R Provenzano, A Azzalin… - … , Biology and Medicine, 2020 - Elsevier
C109 is a potent but poorly soluble FtsZ inhibitor displaying promising activity against
Burkholderia cenocepacia, a high-risk pathogen for cystic fibrosis (CF) sufferers. To harness …

Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999–2009

EV Kurbatova, JS Cavanaugh, T Dalton… - Clinical infectious …, 2013 - academic.oup.com
Background. Pyrazinamide (PZA) is essential in tuberculosis treatment. We describe the
prevalence, trends, and predictors of PZA resistance in Mycobacterium tuberculosis complex …

Synthesis, crystal structure, Hirshfeld surface, computational and antibacterial studies of a 9-phenanthrenecarboxaldehyde-based thiodihydropyrimidine derivative

A Huseynzada, M Mori, F Meneghetti… - Journal of Molecular …, 2022 - Elsevier
We report herein the synthesis of a new biologically active 3, 4-dihydropyrimidin-2 (1H)-
thione derivative (4) from 9-phenanthrenecarboxaldehyde, thiourea, and methyl …

A multilaboratory, multicountry study to determine MIC quality control ranges for phenotypic drug susceptibility testing of selected first-line antituberculosis drugs …

K Kaniga, DM Cirillo, S Hoffner, NA Ismail… - Journal of Clinical …, 2016 - Am Soc Microbiol
Our objective was to establish reference MIC quality control (QC) ranges for drug
susceptibility testing of antimycobacterials, including first-line agents, second-line …

Synthesis, crystal structure and antibacterial studies of dihydropyrimidines and their regioselectively oxidized products

AE Huseynzada, C Jelch, HVN Akhundzada… - RSC …, 2021 - pubs.rsc.org
The syntheses and investigations of new biologically active derivatives of
dihydropyrimidines by Biginelli reaction in the presence of copper triflate are reported. Due …

Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis

JC Palomino, A Martin, A Von Groll… - Journal of microbiological …, 2008 - Elsevier
Tuberculosis still represents a major public health problem, especially in low-resource
countries where the burden of the disease is more important. Multidrug-resistant and …

'ZS-MDR-TB' versus 'ZR-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility

Y Zhang, K Chiu Chang, CC Leung… - Emerging microbes & …, 2012 - Taylor & Francis
Indispensable for shortening treatment of drug-susceptible tuberculosis (TB), pyrazinamide
(PZA, Z) is also essential in the treatment of multidrug-resistant (MDR)-TB. While resistance …